Bergenbio ASA (BGBIO) — Financial Flexibility Index
Bergenbio ASA (BGBIO) has a Financial Flexibility Index of -4.63x as of December 2024. Free cash flow of Nkr-153.24 Million (operating CF Nkr-153.24 Million minus capex Nkr0.00) represents -5% of total liabilities (Nkr33.09 Million). Check Bergenbio ASA (BGBIO) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bergenbio ASA Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Bergenbio ASA across 10 annual periods. See Bergenbio ASA short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bergenbio ASA (2015–2024)
Year-by-year free cash flow to debt coverage for Bergenbio ASA. For the full company profile including market capitalisation, see Bergenbio ASA market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.63x | Nkr-153.24 Million | Nkr-153.24 Million | Nkr33.09 Million | ▲ +22.6% |
| 2023 | -5.99x | Nkr-280.50 Million | Nkr-280.50 Million | Nkr46.86 Million | ▼ -62.4% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr-303.34 Million | Nkr65.81 Million | ▼ -33.8% |
| 2020 | -3.45x | Nkr-234.22 Million | Nkr-234.29 Million | Nkr67.97 Million | ▲ +5.2% |
| 2019 | -3.64x | Nkr-184.08 Million | Nkr-184.15 Million | Nkr50.62 Million | ▲ +19.0% |
| 2018 | -4.49x | Nkr-186.48 Million | Nkr-186.71 Million | Nkr41.55 Million | ▲ +9.1% |
| 2017 | -4.94x | Nkr-167.77 Million | Nkr-168.11 Million | Nkr33.99 Million | ▲ +15.4% |
| 2016 | -5.83x | Nkr-124.06 Million | Nkr-124.31 Million | Nkr21.27 Million | ▼ -64.3% |
| 2015 | -3.55x | Nkr-62.65 Million | Nkr-62.90 Million | Nkr17.64 Million | — |